Henry Schein Bolsters Homecare Solutions with Acentus Acquisition

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has strengthened its position in the homecare medical supplies market with the acquisition of substantially all the assets of Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). The acquisition, announced on November 20, 2024, and completed on January 16, 2025, brings Acentus' annual revenue of approximately $35 million to Henry Schein's homecare medical products platform, now with an annual revenue base in excess of $350 million.

Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein, bringing their expertise and experience in the product category and the healthcare industry. This acquisition reinforces Henry Schein's strategic commitment to the homecare medical supplies market, following its earlier acquisitions of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023.

The acquisition of Acentus is expected to be neutral to 2025 non-GAAP earnings per share and accretive thereafter. Financial terms were not disclosed. Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, commented on the acquisition, "Henry Schein continues to expand upon our national homecare solutions platform to effectively address the evolving needs of our customers, which includes clinics, physician practices, health systems, and patients receiving care at home. The acquisition of Acentus represents an important step towards strengthening our position within the home medical supply market. By directly delivering CGM products to patients' homes, we are enhancing our ability to serve our valued customers and drive growth."

The acquisition of Acentus by Henry Schein is a strategic move that strengthens the company's position in the homecare medical supplies market, expands its product offering, increases its revenue base, and attracts and retains talent. This acquisition is expected to contribute to Henry Schein's long-term growth and success in the home medical supply market.